TransMedics Group

TMDXleader

TransMedics invented warm machine perfusion for organs, transforming the transplant industry by keeping donor hearts, lungs, and livers viable for far longer — increasing the number of viable transplants.

⇄ Compare

Productos e Ingresos

Participación de Ingresos por Producto

Desglose de Ingresos ($403M)

Datos estáticos (cargando finanzas en tiempo real…)

OCS Product Sales (68%)

NOCP Services (32%)

Composición de segmentos y clientes principales

Detalles del producto

Organ Care System (OCS) — Heart55%

Portable device that keeps donor hearts warm and beating outside the body, extending viability and enabling distant transplants.

OCS Lung & Liver35%

Lung and liver perfusion systems providing the same warm ischemia-time extension for thoracic and abdominal organs.

National OCS Program (NOCP)10%

Turnkey organ retrieval, transport, and transplant logistics service operated by TransMedics staff.

Relaciones en la Cadena de Suministro

Socios

Johnson & Johnson

Surgical tools for OCS procedures

Impacto: moderate

Contexto macro y de mercado

헬스케어Noticias del sector

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Próximos catalizadores

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Últimas noticias

Cargando noticias...

Análisis IA

Haz clic en "Obtener Análisis IA" para un análisis de cadena de suministro de TransMedics Group impulsado por IA.

Información de la Empresa

Sede Central

Andover, Massachusetts, USA

Fundación

1998

Empleados

1,100

Sitio Web

transmedics.com

Estado del sector — 헬스케어

Noticias del sector